Foxk1 promotes cell proliferation and represses myogenic differentiation by regulating Foxo4 and Mef2

Journal of Cell Science

Volumn 125, Issue 22, 2012, Pages 5329-5337

  Shi, Xiaozhong ^a   Wallis, Alicia M ^a   Gerard, Robert D ^b   Voelker, Kevin A ^c,d   Grange, Robert W ^c,d   DePinho, Ronald A ^e   Garry, Mary G ^a   Garry, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Foods and Exercise ^*  (United States)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell differentiation; Cell proliferation; Foxk1; Foxo4; Mef2

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXK1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; MUSCLE CELL; MUSCLE PROGENITOR CELL; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STEM CELL;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA; FORKHEAD TRANSCRIPTION FACTORS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; PROTEIN BINDING; REGENERATION; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84873543649     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.105239     Document Type: Article

References (59)

1. Alexander, M. S., Shi, X., Voelker, K. A., Grange, R. W., Garcia, J. A., Hammer, R. E. and Garry, D. J. (2010). Foxj3 transcriptionally activates Mef2c and regulates adult skeletal muscle fiber type identity. Dev. Biol. 337, 396-404.
2. Aoki, K., Barker, C., Danthinne, X., Imperiale, M. J. and Nabel, G. J. (1999). Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol. Med. 5, 224-231.
3. Bassel-Duby, R. and Olson, E. N. (2006). Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75, 19-37.
4. Bettelli, E., Dastrange, M. and Oukka, M. (2005). Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102, 5138-5143.
5. Biressi, S. and Rando, T. A. (2010). Heterogeneity in the muscle satellite cell population. Semin. Cell Dev. Biol. 21, 845-854.
6. Black, B. L. and Olson, E. N. (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167-196.
7. Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y. and Dynlacht, B. D. (2005). An initial blueprint for myogenic differentiation. Genes Dev. 19, 553-569.
8. Buckingham, M. and Vincent, S. D. (2009). Distinct and dynamic myogenic populations in the vertebrate embryo. Curr. Opin. Genet. Dev. 19, 444-453.
9. Burgering, B. M. (2008). A brief introduction to FOXOlogy. Oncogene 27, 2258-2262.
10. Castrillon, D. H., Miao, L., Kollipara, R., Horner, J. W. and DePinho, R. A. (2003). Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301, 215-218.
11. Chuang, W. J., Yeh, I. J., Hsieh, Y. H., Liu, P. P., Chen, S. W. and Jeng, W. Y. (2002). 1H, 15N and 13C resonance assignments for the DNA-binding domain of myocyte nuclear factor (Foxk1). J. Biomol. NMR 24, 75-76.
12. Clark, K. L., Halay, E. D., Lai, E. and Burley, S. K. (1993). Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364, 412-420.
13. Furuyama, T., Kitayama, K., Shimoda, Y., Ogawa, M., Sone, K., Yoshida-Araki, K., Hisatsune, H., Nishikawa, S., Nakayama, K., Nakayama, K. et al. (2004). Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279, 34741- 34749.
14. Gallardo, T. D., Hammer, R. E. and Garry, D. J. (2003). RNA amplification and transcriptional profiling for analysis of stem cell populations. Genesis 37, 57-63.
15. Garry, D. J., Yang, Q., Bassel-Duby, R. and Williams, R. S. (1997). Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev. Biol. 188, 280-294.
16. Garry, D. J., Meeson, A., Elterman, J., Zhao, Y., Yang, P., Bassel-Duby, R. and Williams, R. S. (2000). Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl. Acad. Sci. USA 97, 5416-5421.
17. Goetsch, S. C., Hawke, T. J., Gallardo, T. D., Richardson, J. A. and Garry, D. J. (2003). Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics 14, 261-271.
18. Gomis, R. R., Alarcón, C., He, W., Wang, Q., Seoane, J., Lash, A. and Massagué, J. (2006). A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 103, 12747-12752.
19. Hanashima, C., Shen, L., Li, S. C. and Lai, E. (2002). Brain factor-1 controls the proliferation and differentiation of neocortical progenitor cells through independent mechanisms. J. Neurosci. 22, 6526-6536.
20. Hannenhalli, S. and Kaestner, K. H. (2009). The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10, 233-240.
21. Hawke, T. J., Jiang, N. and Garry, D. J. (2003a). Absence of p21CIP rescues myogenic progenitor cell proliferative and regenerative capacity in Foxk1 null mice. J. Biol. Chem. 278, 4015-4020.
22. Hawke, T. J., Meeson, A. P., Jiang, N., Graham, S., Hutcheson, K., DiMaio, J. M. and Garry, D. J. (2003b). p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. Am. J. Physiol. Cell Physiol. 285, C1019-C1027.
23. Hinits, Y. and Hughes, S. M. (2007). Mef2s are required for thick filament formation in nascent muscle fibres. Development 134, 2511-2519.
24. Ho, K. K., Myatt, S. S. and Lam, E. W. (2008). Many forks in the path: cycling with FoxO. Oncogene 27, 2300-2311.
25. Hosaka, T., Biggs, W. H., 3rd, Tieu, D., Boyer, A. D., Varki, N. M., Cavenee, W. K. and Arden, K. C. (2004). Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101, 2975-2980.
26. Ivanciu, L., Gerard, R. D., Tang, H., Lupu, F. and Lupu, C. (2007). Adenovirusmediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27, 310-316.
27. Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H. et al. (2004). Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123.
28. Kuang, S. and Rudnicki, M. A. (2008). The emerging biology of satellite cells and their therapeutic potential. Trends Mol. Med. 14, 82-91.
29. Liu, P. P., Chen, Y. C., Li, C., Hsieh, Y. H., Chen, S. W., Chen, S. H., Jeng, W. Y. and Chuang, W. J. (2002). Solution structure of the DNA-binding domain of interleukin enhancer binding factor 1 (FOXK1a). Proteins 49, 543-553.
30. Mauro, A. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495.
31. Meeson, A. P., Shi, X., Alexander, M. S., Williams, R. S., Allen, R. E., Jiang, N., Adham, I. M., Goetsch, S. C., Hammer, R. E. and Garry, D. J. (2007). Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells. EMBO J. 26, 1902-1912.
32. Molkentin, J. D., Black, B. L., Martin, J. F. and Olson, E. N. (1996). Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16, 2627-2636.
33. Myatt, S. S. and Lam, E. W. (2007). The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7, 847-859.
34. Naya, F. J. and Olson, E. (1999). MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11, 683-688.
35. Naya, F. J., Wu, C., Richardson, J. A., Overbeek, P. and Olson, E. N. (1999). Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126, 2045-2052.
36. Paik, J. H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R. et al. (2007). FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323.
37. Partridge, L. and Brüning, J. C. (2008). Forkhead transcription factors and ageing. Oncogene 27, 2351-2363.
38. Perrone, L., Pasca di Magliano, M., Zannini, M. and Di Lauro, R. (2000). The thyroid transcription factor 2 (TTF-2) is a promoter-specific DNA-binding independent transcriptional repressor. Biochem. Biophys. Res. Commun. 275, 203-208.
39. Potthoff, M. J. and Olson, E. N. (2007). MEF2: a central regulator of diverse developmental programs. Development 134, 4131-4140. Potthoff, M. J., Arnold, M. A., McAnally, J., Richardson, J. A., Bassel-Duby, R. and
40. Potthoff, M. J., Arnold, M. A., McAnally, J., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2007). Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol. Cell. Biol. 27, 8143-8151.
41. Sadowski, I., Bell, B., Broad, P. and Hollis, M. (1992). GAL4 fusion vectors for expression in yeast or mammalian cells. Gene 118, 137-141.
42. Seoane, J., Le, H. V., Shen, L., Anderson, S. A. and Massagué, J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211-223.
43. Shi, X. and Garry, D. J. (2006). Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692-1708.
44. Shi, X. and Garry, D. J. (2010). Myogenic regulatory factors transactivate the Tceal7 gene and modulate muscle differentiation. Biochem. J. 428, 213-221.
45. Shi, X. and Garry, D. J. (2012). Sin3 interacts with Foxk1 and regulates myogenic progenitors. Mol. Cell. Biochem. 366, 251-258.
46. Shi, X., Bowlin, K. M. and Garry, D. J. (2010). Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic progenitors. Stem Cells 28, 462-469.
47. Shi, X., Seldin, D. C. and Garry, D. J. (2012). Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem. J. 446, 349-357.
48. Shimeld, S. M., Degnan, B. and Luke, G. N. (2010). Evolutionary genomics of the Fox genes: origin of gene families and the ancestry of gene clusters. Genomics 95, 256-260.
49. Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D. et al. (2005). The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280, 20814-20823.
50. Sternberg, E. A., Spizz, G., Perry, W. M., Vizard, D., Weil, T. and Olson, E. N. (1988). Identification of upstream and intragenic regulatory elements that confer celltype-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol. Cell. Biol. 8, 2896-2909.
51. Ten Broek, R. W., Grefte, S. and Von den Hoff, J. W. (2010). Regulatory factors and cell populations involved in skeletal muscle regeneration. J. Cell. Physiol. 224, 7-16.
52. Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C. et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339.
53. Tsai, K. L., Huang, C. Y., Chang, C. H., Sun, Y. J., Chuang, W. J. and Hsiao, C. D. (2006). Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins. J. Biol. Chem. 281, 17400-17409.
54. van der Vos, K. E. and Coffer, P. J. (2008). FOXO-binding partners: it takes two to tango. Oncogene 27, 2289-2299.
55. Weigel, D. and Jäckle, H. (1990). The fork head domain: a novel DNA binding motif of eukaryotic transcription factors? Cell 63, 455-456.
56. Weigel, D, Jürgens, G., Küttner, F., Seifert, E. and Jäckle, H. (1989). The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57, 645-658.
57. Wijchers, P. J., Burbach, J. P. and Smidt, M. P. (2006). In control of biology: of mice, men and Foxes. Biochem. J. 397, 233-246.
58. Yang, X. F., Fang, P., Meng, S., Jan, M., Xiong, X., Yin, Y. and Wang, H. (2009). The FOX transcription factors regulate vascular pathology, diabetes and Tregs. Front. Biosci. (Schol Ed.) 1, 420-436.
59. Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H. and Goldberg, A. L. (2007). FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6, 472-483.